121 related articles for article (PubMed ID: 17474456)
1. [Treatment of chronic myelogenous leukemia with imatinib: current and future therapeutic strategies].
Yagasaki F
Nihon Rinsho; 2007 Jan; 65 Suppl 1():505-10. PubMed ID: 17474456
[No Abstract] [Full Text] [Related]
2. Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
Stagno F; Vigneri P; Del Fabro V; Stella S; Massimino M; Berretta S; Messina A; Di Raimondo F
Leuk Res; 2009 Jun; 33(6):e17. PubMed ID: 19036439
[No Abstract] [Full Text] [Related]
3. [Treatment strategies for chronic myeloid leukemia].
Jinnai I
Rinsho Ketsueki; 2005 Jan; 46(1):1-6. PubMed ID: 16708910
[No Abstract] [Full Text] [Related]
4. Imatinib for chronic myeloid leukemia: the impact of its effectiveness and long-term side effects.
Smith BD
J Natl Cancer Inst; 2011 Apr; 103(7):527-9. PubMed ID: 21422404
[No Abstract] [Full Text] [Related]
5. Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
Cashen A; DiPersio JF; Khoury H
J Clin Oncol; 2003 Nov; 21(22):4255-6. PubMed ID: 14615462
[No Abstract] [Full Text] [Related]
6. Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease.
Franceschino A; Tornaghi L; Piazza R; Pogliani E; Gambacorti Passerini C
Haematologica; 2006 Jun; 91(6 Suppl):ECR14. PubMed ID: 16785120
[No Abstract] [Full Text] [Related]
7. Current use of imatinib in the treatment of chronic myeloid leukemia.
O'Dwyer M
Haematologica; 2003 Mar; 88(3):241-4. PubMed ID: 12651257
[No Abstract] [Full Text] [Related]
8. Clinical characteristics and hematologic responses to Imatinib in patients with chronic phase myeloid leukemia (CML) at Cipto Mangunkusumo Hospital.
Reksodiputro AH; Syafei S; Prayogo N; Karsono B; Rinaldi I; Rajabto W; Mulansari NA
Acta Med Indones; 2010 Jan; 42(1):2-5. PubMed ID: 20305324
[TBL] [Abstract][Full Text] [Related]
9. [Imatinib therapy for patients with chronic myelogenous leukemia].
Kawai Y; Ueda T
Nihon Rinsho; 2004 Jul; 62(7):1325-31. PubMed ID: 15283151
[TBL] [Abstract][Full Text] [Related]
10. [Current status and future perspective in imatinib therapy against CML].
Tojo A
Rinsho Ketsueki; 2011 Oct; 52(10):1603-9. PubMed ID: 21971237
[No Abstract] [Full Text] [Related]
11. [Targeted therapy with imatinib has reformed the treatment of chronic myeloid leukemia].
Nielsen JL
Ugeskr Laeger; 2003 May; 165(20):2111. PubMed ID: 12812107
[No Abstract] [Full Text] [Related]
12. Investigational strategies in chronic myelogenous leukemia.
Cortes JE; O'Brien SM; Giles F; Alvarez RH; Talpaz M; Kantarjian HM
Hematol Oncol Clin North Am; 2004 Jun; 18(3):619-39, ix. PubMed ID: 15271396
[TBL] [Abstract][Full Text] [Related]
13. Trial results of a new combination therapy for myeloid leukaemia.
Leach S; Richardson C; Vowles JK; Charlton L
Nurs Times; 2002 Jul 16-22; 98(29):32-4. PubMed ID: 12168413
[TBL] [Abstract][Full Text] [Related]
14. [Attentive questions about treatment of chronic myelogenous leukemia with imatinib mesylate].
Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):433-5. PubMed ID: 17147242
[No Abstract] [Full Text] [Related]
15. Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemia.
Champlin RE; Kantarjian H
Clin Adv Hematol Oncol; 2003 Jul; 1(7):398-400. PubMed ID: 16258420
[No Abstract] [Full Text] [Related]
16. Management of conjunctival chemosis secondary to imatinib treatment for chronic myelogenous leukemia.
Jin J; Chen H; Cao L
Leuk Res; 2009 Jun; 33(6):e18-9. PubMed ID: 19108890
[No Abstract] [Full Text] [Related]
17. [Treatment of chronic myeloid leukemia with imatinib].
Ohnishi K
Gan To Kagaku Ryoho; 2011 May; 38(5):746-8. PubMed ID: 21702117
[No Abstract] [Full Text] [Related]
18. Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate.
Yoon JY; Kumar R; Aloyz R; Johnston JB
Leuk Res; 2011 Sep; 35(9):e179-80. PubMed ID: 21802141
[No Abstract] [Full Text] [Related]
19. Chronic myelogenous leukemia therapy beyond imatinib.
Deininger M
Clin Adv Hematol Oncol; 2010 Mar; 8(3):178-80. PubMed ID: 20400933
[No Abstract] [Full Text] [Related]
20. Imatinib in chronic myeloid leukemia.
Krause SW; Holler E
N Engl J Med; 2007 Apr; 356(17):1780; author reply 1780. PubMed ID: 17460235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
